Skip to main content
. 2015 Feb 11;10(2):e0117118. doi: 10.1371/journal.pone.0117118

Fig 5. Variation over time of immune proliferation in two groups of HIV-1-infected patients starting their first antiretroviral treatment at different baseline CD4+ T-cell counts (late presenters [grey line] ≤200 cells/μL; early presenters [black line] >200 cells/μL).

Fig 5

Medians and interquartile ranges are shown.